Skip to main content
Clinical Trials/EUCTR2018-003321-29-DE
EUCTR2018-003321-29-DE
Active, not recruiting
Phase 1

Clinical relevance of the antimicrobial resistance testing in the treatment of chronic wounds with antiseptics - AntiSeptic

RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty0 sites0 target enrollmentJuly 1, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Decubitus, acute or chronic wounds (open wounds existing = 14 days)
Sponsor
RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty

Eligibility Criteria

Inclusion Criteria

  • 1\.Age \= 18 years
  • 2\.Decubitus OR secondary healing acute and chronic wounds
  • 3\.Positively tested wound swab for bacteria (incl. multi\-resistant bacteria)
  • 4\.Patient is capable of understanding the nature, significance and consequence of the clinical trial
  • 5\.Given written consent
  • 6\.Women of child bearing potential (WOCBP) who apply appropriate methods of contraception throughout the duration of the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40

Exclusion Criteria

  • 1\.Occlusive dressing (e.g. VAC)
  • 2\.Pregnant or lactating women
  • 3\.Known allergies against investigational products

Outcomes

Primary Outcomes

Not specified

Similar Trials